Intravitreal Pegcetaoplan May Control Lesion Growth in Geographic Atrophy
An AAO 2021 presentation reviewed clinical trial data of intravitreal pegcetacoplan, a targeted C3 inhibitor, in controlling lesion growth in patients with geographic atrophy.
All articles by Lizette Borreli
Teprotumumab Proves Efficacious for Proptosis in Thyroid Eye Disease
Presenting at AAO 2021, researchers examined the efficacy of intravenous infusions of teprotumumab, an IGF-IR inhibitor, in patients with thyroid eye disease with low inflammation.
Wearable Device That May Prevent Epilepsy-Related Death Receives Funding
Neurava, an Indiana startup developing a wearable device to monitor the potential risk for sudden, unexpected death in epilepsy (SUDEP), receives funding to complete the final prototype.
- Loading...
Loading...
Next post in Epilepsy
Loading... 
Loading...